Addex Therapeutics Ltd (ADXN) — Cash Flow Quality Index
Addex Therapeutics Ltd (ADXN) has a Cash Flow Quality Index of -0.21x as of June 2024. Operating cash flow of $-2.76 Million is below net income of $12.88 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore cash flow conversion of Addex Therapeutics Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Addex Therapeutics Ltd Cash Flow Quality Index (2024–2024)
Historical Cash Flow Quality Index for Addex Therapeutics Ltd across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Addex Therapeutics Ltd (ADXN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Addex Therapeutics Ltd (2024–2024)
Year-by-year earnings quality comparison for Addex Therapeutics Ltd. For live market cap and the full company financial profile, see Addex Therapeutics Ltd market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -0.76x | $-5.37 Million | $7.06 Million | — |